Glenmark Pharmaceuticals Recalls Pravastatin Sodium Tablets 80mg
Glenmark Pharmaceuticals Inc., USA is recalling specific lots of Pravastatin Sodium Tablets 80mg due to Current Good Manufacturing Practice (CGMP) deviations. The recall applies to affected lots distributed nationwide and was initiated voluntarily by the firm.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is FDA Class II and voluntary with no reported illness or injury. The hazard involves CGMP deviations, which represent a potential quality concern but without specific evidence of harm, placing this in the Moderate category.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling certain lots of Pravastatin Sodium Tablets 80mg (90-count bottles, NDC 68462-198-90) manufactured in India and distributed U.S. nationwide. The affected lots are: 17221771 (exp. Aug-25), 17230930 (exp. Apr-26), 17230931 (exp. Apr-26), 17231252 (exp. May-26), 17231274 (exp. May-26), 17231855 (exp. Aug-26), 17231916 (exp. Aug-26), 17231917 (exp. Aug-26), and 17231945 (exp. Aug-26).
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The recall is voluntary and was initiated by the firm on March 13, 2025. The FDA classified this recall as Class II on April 8, 2025.
Consumers who have bottles of Pravastatin Sodium Tablets 80mg from the affected lots should contact their pharmacist or healthcare provider for guidance. Patients should not stop taking their medication without consulting their healthcare provider.
The recalled product
- Product
- PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)
- Brand
- PRAVASTATIN SODIUM
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription Statin
- Hazard
- cgmp-deviations
- manufacturing-control
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 17221771
- exp. date Aug-25 17230930
- exp. date Apr-26 17230931
- exp. date Apr-26 17231252
- exp. date May-26 17231274
- exp. date May-26 17231855
- exp. date Aug-26 17231916
- exp. date Aug-26 17231917
- exp. date Aug-26 17231945
- exp. date Aug-26
UPCs (2)
- 0368462195901
- 0368462198902
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PRAVASTATIN SODIUM
- ModeratePravastatin Sodium 20mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModeratePravastatin Sodium Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModeratePravastatin Sodium Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-16
- HighPravastatin Sodium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2024-07-24
- HighFDA Recalls Pravastatin Sodium Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2023-03-08
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22